(22R)-Budesonide
CAS: 51372-29-3
Ref. 3D-FB19347
| 1mg | Descatalogado | ||
| 2mg | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado |
Información del producto
Nombre:
(22R)-Budesonide
Producto controlado
Sinónimos:
- (11b,16a)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
- (11β,16α)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
- 16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione
- 2H-Naphth[2′,1′:4,5]indeno[1,2-d][1,3]dioxole, pregna-1,4-diene-3,20-dione deriv.
- Dexbudesonide
- Pregna-1,4-diene-3,20-dione, 16,17-[(1R)-butylidenebis(oxy)]-11,21-dihydroxy-, (11β,16α)-
- Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, [11β,16α(R)]-
Descripción:
(22R)-Budesonide is a steroid that has been used for the treatment of asthma, chronic cough, and bowel disease. It is also used to treat rhinitis symptoms in patients with allergic rhinitis or chronic sinusitis. (22R)-Budesonide inhibits the inflammatory response by inhibiting the release of inflammatory mediators such as eosinophil cationic protein, which are released during an allergic reaction. The drug is also effective in treating bacterial rhinosinusitis, although it has not been tested against other types of respiratory infections.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
430.53 g/mol
Fórmula:
C25H34O6
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
